Published on Journal of Alzheimer's Disease (https://www.j-alz.com)

Home > Additional use of Abeta42/Abeta40 ratio with cerebrospinal fluid biomarkers P-Tau and Abeta42 increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice

Additional use of Abeta42/Abeta40 ratio with cerebrospinal fluid biomarkers P-Tau and Abeta42 increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice

Manuscript Number: 

13-1838R1

Author(s): 
Guerric DidierLaurent, Marie-Christine Escanye, Clotilde Latarche, Catherine Malaplate-Armand, Jean-Luc Olivier, Mathilde Sauvée
Source URL: https://www.j-alz.com/node/31212?id=2127